Skip to main content
Thomas Clozel

Thomas Clozel

Cofounder and CEO, Owkin
Thomas is a very french former physician, co-founder and CEO of OWKIN, the first data driven end to end biopharma unicorn bringing first and best in class AI driven therapeutics and diagnosis to patients. Replacing intuition by data, augmentation by accélération, discovering new biology before ways to modulate it. Non operational cofounder of BioPtimus, first multiscale foundation model for human biology, and Cure51, creating the largest database of cancer outliers - both reinforcing and accelerating OWKIN mission in strong synergies. Venture Advisor for Sofinnova, and investor in one health startups. (environnement, health, doctor to patient interaction and AI to human interaction).